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Cancer is one of the leading causes of death worldwide. Observational evidence suggests that approximately 30-40% of cancer cases are potentially preventable via food choices and the modification of nutritional factors. Milk contains numerous bioactive substances that could potentially affect risk and progression of cancer, as listed in table 1 .
Demonstrating a specific molecular effect of nutrients or other bioactive food components on human cancer, in which a series of genetic and epigenetic changes has occurred over years or decades, is logistically difficult. Also, disentangling the effects of various foods, specific dietary constituents, and related lifestyle factors and characteristics is very challenging. Interpretation of the results from randomized trials in cancer prevention has been difficult because these studies have been relatively short-term in nature. Available data and current evidence suggest a possible role for milk intake, or certain bioactive constituents of milk (e.g. calcium, vitamin D), in the etiology of cancer [1] . Separating the effects of the intake of milk per se and bioactive components may not be possible or necessary for translation into public health recommendations. In countries in which milk and other dairy products are consumed, these foods are the major source of calcium, so evidence linking calcium intake to cancer is highly relevant to dietary recommendations regarding milk intake. Also, milk is an important source of dietary vitamin D in countries in which milk is fortified with this compound.
Numerous observational epidemiological studies have examined the relationship between milk intake and risk for colorectal cancer, and the majority have identified a protective effect of milk. For example, Cho et al. [2] conducted a large pooled analysis of data from ten cohorts (n = 534,536) from five countries, in whom 4,992 individuals were diagnosed with colorectal cancer at follow-up. Individuals who consumed more than a glass of milk (≥250 g)/day had a 15% reduced risk of developing colorectal cancer (relative risk 0.85, 95% CI 0.78-0.94), compared to those who consumed <70 g/day. Similarly, calcium intake has been found to be inversely associated with reduced risk for colorectal cancer in the majority of observational studies. Both dietary calcium and total calcium intake (including supplements) appear to be protective in a dose-response manner up to a threshold of about 1,200-1,400 mg/day.
In two clinical trials, calcium supplements have been shown to reduce risk for recurrence of adenomatous polyps. At doses of 1,200 and 2,000 mg/day for 3-4 years, a reduction in the risk for recurrent adenoma was observed (odds ratio 0.74, 95% CI 0.58-0.95) [3] . Calcium supplementation has not been observed to reduce risk for colon cancer. Mechanisms of action that have been proposed to explain a protective effect of milk intake on colorectal cancer include biological activities of calcium, vitamin D, magnesium, butyric acid produced by microflora, and conjugated linoleic acid, all of which have been observed to inhibit cell proliferation and tumor cell growth in laboratory studies.
Numerous observational epidemiological studies have examined whether milk, dairy foods and/or calcium are associated with risk for prostate cancer. The relationship between intake of milk and/or dairy foods and prostate cancer risk is suggestive of an adverse, rather than a protective, effect. For example, one recent meta-analysis of 11 cohort studies reported a summary relative risk of 1.11 (95% CI 1.03-1.19) per serving for total dairy foods, 1.06 (95% CI 0.91-1.23) for milk, and 1.11 (95% CI 0.99, 1.25) for cheese [4] . High calcium intake (>1,000 mg/day) from both food and supplements has been observed to be associated with increased risk for advanced or fatal prostate cancer. Mechanisms suggested to explain these findings are not well supported.
Results from epidemiological studies examining the relationship between intake of dairy foods and breast or ovarian cancer risk are not consistent. Three randomized clinical trials have tested whether changing diet composition can affect primary breast cancer risk or recurrence and/or survival in women diagnosed with early stage breast cancer. Although the type of milk and dairy products consumed were targeted in these trials, the total intake of these foods changed minimally and was unrelated to cancer outcomes. Animal studies have suggested that galactose may be toxic to ovarian cells, but results from epidemiologic studies that have examined the relationship between ovarian cancer risk and milk and/or lactose intakes are mixed.
The World Cancer Research Fund report concluded that there is a probable link between milk intake and colorectal cancer in decreasing risk, and a probable link between diets high in calcium and prostate cancer in increasing risk [1] . Current dietary guidelines for cancer prevention encourage meeting recommended levels of calcium intake primarily through food choices rather than supplements, and choosing low-fat or nonfat dairy foods [1, 5] .
